BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/24/2017 12:54:04 AM | Browse: 402 | Download: 593
Publication Name World Journal of Hepatology
Manuscript ID 33640
Country China
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Value of quality of life analysis in liver cancer: A clinician’s perspective
Manuscript Source Invited Manuscript
All Author List Leung Li and Winnie Yeo
Funding Agency and Grant Number
Corresponding Author Winnie Yeo, MBBS (Lond), AKC (Lond), FHKCP(HK), FHKAM(HK), FRCP (Lond), FRCP (Edin), Professor, Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, the Chinese University of Hong Kong, Shatin, NT, Hong Kong, China. winnieyeo@cuhk.edu.hk
Key Words Hepatocellular carcinoma; Health related quality of life; Palliative care; Prognosis; Survival; The European Organisation for Research and Treatment of Cancer QLQ-C30; QLQ-HCC18; Index score; Functional Assessment of Cancer Therapy; EQ-5D; Spitzer; Short form 36; FHSI-8; World Health Organization Quality of Life Assessment
Core Tip Health related quality of life (HRQOL) is an important clinical parameter and research endpoint in hepatocellular carcinoma (HCC) patients. Instruments discussed are short form (SF)-36, SF-12, EQ-5D, World Health Organization Quality of Life Assessment (WHOQOL) 100, WHOQOL-BREF, the European Organi­sa­tion for Research and Treatment of Cancer (EORTC) QLQ-C30, Functional Assessment of Cancer Therapy (FACT)-G, Spitzer QoL index, EORTC QLQ-HCC18, FACT-Hep, FHSI-8, TOI. Important utilization of HRQOL included measure­ment and monitoring of HRQOL, treatment endpoint in clinical trial, prognostication of survival, benchmarking of palliative care service and health care valuation. Various difficulties in using HRQOL data in research and clinical practice, including choosing a suitable instrument, missing data, data interpretation, analysis and presentation are explained. Potential solutions are also discussed.
Citation Li L, Yeo W. Value of quality of life analysis in liver cancer: A clinician’s perspective. World J Hepatol 2017; 9(20): 867-883
Received
2017-02-22 08:32
Peer-Review Started
2017-02-26 23:58
To Make the First Decision
2017-03-27 12:15
Return for Revision
2017-03-29 15:02
Revised
2017-04-10 21:16
Second Decision
2017-05-16 04:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-05-24 00:54
Articles in Press
2017-05-24 00:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-07-08 05:44
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com